SILO PHARMA, INC. Employee Benefits and Share-based Compensation
SILO PHARMA, INC. (SILO) reported Employee Benefits and Share-based Compensation of $222.68 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-13
- SILO PHARMA, INC. employee benefits and share-based compensation for the quarter ending 2026-06-30 was $222.68K, a 14.02% increase year-over-year.
- SILO PHARMA, INC. employee benefits and share-based compensation for the quarter ending 2026-03-31 was $242.63K, a 35.95% increase year-over-year.
- SILO PHARMA, INC. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $229.42K, a 41.97% decline year-over-year.
- SILO PHARMA, INC. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $227.13K, a 33.81% increase year-over-year.
- SILO PHARMA, INC. employee benefits and share-based compensation for fiscal 2023 was $14.13K, a 90.95% decline from fiscal 2022.
- SILO PHARMA, INC. employee benefits and share-based compensation for fiscal 2022 was $156.05K, a 86.37% increase from fiscal 2021.
- SILO PHARMA, INC. employee benefits and share-based compensation for fiscal 2021 was $83.73K, a 86.28% decline from fiscal 2020.
- SILO PHARMA, INC. employee benefits and share-based compensation for fiscal 2020 was $610.48K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $222.68K 10-Q · filed 2026-08-13 | $465.32K 10-Q · filed 2026-08-13 | $694.73K derived: sum of 3 quarters · filed 2026-08-13 | $921.87K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $242.63K 10-Q · filed 2026-05-14 | $472.05K derived: sum of 2 quarters · filed 2026-05-14 | $699.18K derived: sum of 3 quarters · filed 2026-05-14 | $894.49K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $229.42K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $456.55K derived: sum of 2 quarters · filed 2026-04-14 | $651.85K derived: sum of 3 quarters · filed 2026-08-13 | $830.32K POS AM · filed 2026-04-14 |
| 2025-09-30 | $227.13K 10-Q · filed 2025-11-13 | $422.44K derived: sum of 2 quarters · filed 2026-08-13 | $600.91K 10-Q · filed 2025-11-13 | $996.22K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $195.31K 10-Q · filed 2026-08-13 | $373.77K 10-Q · filed 2026-08-13 | $769.08K derived: sum of 3 quarters · filed 2026-08-13 | $938.82K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $178.47K 10-Q · filed 2026-05-14 | $573.78K derived: sum of 2 quarters · filed 2026-05-14 | $743.51K derived: sum of 3 quarters · filed 2026-05-14 | $911.90K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $395.31K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $565.05K derived: sum of 2 quarters · filed 2026-04-14 | $733.43K derived: sum of 3 quarters · filed 2026-04-14 | $906.77K POS AM · filed 2026-04-14 |
| 2024-09-30 | $169.74K 10-Q · filed 2025-11-13 | $338.12K derived: sum of 2 quarters · filed 2025-11-13 | $511.46K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $168.38K 10-Q · filed 2025-08-13 | $341.73K 10-Q · filed 2025-08-13 | ||
| 2023-12-31 | $1.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $5.65K derived: sum of 2 quarters · filed 2025-03-28 | $9.89K derived: sum of 3 quarters · filed 2025-03-28 | $14.13K 10-K · filed 2025-03-28 |
| 2023-09-30 | $4.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.47K derived: sum of 2 quarters · filed 2024-11-12 | $12.71K 10-Q · filed 2024-11-12 | $72.83K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $4.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $8.47K 10-Q · filed 2024-08-13 | $68.60K derived: sum of 3 quarters · filed 2024-08-13 | $90.28K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.24K 10-Q · filed 2024-05-13 | $64.36K derived: sum of 2 quarters · filed 2024-05-13 | $86.04K derived: sum of 3 quarters · filed 2024-05-13 | $115.28K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $60.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $81.80K derived: sum of 2 quarters · filed 2024-03-25 | $111.04K derived: sum of 3 quarters · filed 2024-03-25 | $156.05K 10-K · filed 2024-03-25 |
| 2022-09-30 | $21.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $50.92K derived: sum of 2 quarters · filed 2023-11-13 | $95.92K 10-Q · filed 2023-11-13 | $95.92K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $29.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $74.25K 10-Q · filed 2023-08-11 | $74.25K derived: sum of 3 quarters · filed 2023-08-11 | $74.25K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $45.01K 10-Q · filed 2023-05-12 | $45.01K derived: sum of 2 quarters · filed 2023-05-12 | $45.01K derived: sum of 3 quarters · filed 2023-05-12 | $45.01K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | $0.00 derived: sum of 3 quarters · filed 2023-03-24 | $83.73K 10-K · filed 2023-03-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $83.73K 10-Q · filed 2022-11-10 | $83.73K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $83.73K 10-Q · filed 2022-08-01 | $83.73K derived: sum of 3 quarters · filed 2022-08-01 | $83.73K derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $83.73K 10-Q · filed 2022-05-13 | $83.73K derived: sum of 2 quarters · filed 2022-05-13 | $83.73K derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $610.48K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $610.48K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $610.48K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |